Re-examining the role of ventral tegmental area dopaminergic neurons in motor activity and reinforcement by chemogenetic and optogenetic manipulation in mice
The precise contributions of ventral tegmental area (VTA) dopaminergic (DAergic) neurons to reward-related behaviors are a longstanding hot topic of debate. Whether the activity of VTA DAergic neurons directly modulates rewarding behaviors remains uncertain. In the present study, we investigated the fundamental role of VTA DAergic neurons in reward-related movement and reinforcement by employing dopamine transporter (DAT)-Cre transgenic mice expressing hM3Dq, hM4Di or channelrhodopsin 2 (ChR2) in VTA DAergic neurons through Cre-inducible adeno-associated viral vector transfection. On the one hand, locomotion was tested in an open field to examine motor activity when VTA DAergic neurons were stimulated or inhibited by injection of the hM3Dq or hM4Di ligand clozapine-N-oxide (CNO), respectively. CNO injection to selectively activate or inhibit VTA DAergic neurons significantly increased or decreased locomotor activity, respectively, compared with vehicle injection, indicating that VTA DAergic neuron stimulation is directly involved in the regulation of motor activity. On the other hand, we used the optical intracranial self-stimulation (oICSS) model to investigate the causal link between reinforcement and VTA DAergic neurons. Active poking behavior but not inactive poking behavior was significantly escalated in a frequency- and pulse duration-dependent manner. In addition, microdialysis revealed that the concentration of dopamine (DA) in the nucleus accumbens (NAc) was enhanced by selective optogenetic activation of VTA DAergic neurons. Furthermore, systemic administration of a DA D1 receptor antagonist significantly decreased oICSS reinforcement. Our research profoundly demonstrates a direct regulatory role of VTA DAergic neurons in movement and reinforcement and provides meaningful guidance for the development of novel treatment strategies for neuropsychiatric diseases related to the malfunction of the reward system.
KeywordsVentral tegmental area Dopamine Chemogenetic Optogenetic Motor activity Reinforcement
This work was supported by the National Key R&D Program of China (2017YFC131040), National Natural Science Foundation of China (No. U1502225), National Key R&D Program of China (2016YFC0800907), National Natural Science Foundation of China (81573405), Medical Innovation Program (16CXZ033) and Beijing Nova Program (xx2014A014).
Compliance with ethical standards
Conflict of interest
The authors declare no conflict of interest.
- Bass CE, Grinevich VP, Vance ZB, Sullivan RP, Bonin KD, Budygin EA (2010) Optogenetic control of striatal dopamine release in rats. J Neurochem 114(5):1344–1352Google Scholar
- David V, Matifas A, Gavello-Baudy S, Decorte L, Kieffer BL, Cazala P (2008) Brain regional Fos expression elicited by the activation of mu- but not delta-opioid receptors of the ventral tegmental area: evidence for an implication of the ventral thalamus in opiate reward. Neuropsychopharmacology 33(7):1746–1759CrossRefGoogle Scholar
- Franklin KBJ, Paxinos G (2007) The Mouse Brain in Stereotaxic Coordinates. New York, the United States, Academic PressGoogle Scholar
- Garcia-Ruiz PJ, Martinez Castrillo JC, Desojo LV (2019) Creativity related to dopaminergic treatment: a multicenter study. Elsevier Publishing Parkinsonism Relat Disord. https://www.prd-journal.com/article/S1353-8020(19)30056-2. Accessed 22 Feb 2007
- Minogianis EA, Shams WM, Mabrouk OS, Wong JT, Brake WG, Kennedy RT, du Souich P, Samaha AN (2018) Varying the rate of intravenous cocaine infusion influences the temporal dynamics of both drug and dopamine concentrations in the striatum. Federation of European Neuroscience Societies and John Wiley & Sons Publishing Eur J Neurosci. https://doi.org/10.1111/ejn.13941. Accessed 14 May 2018
- Schrantee A, Tamminga HG, Bouziane C, Bottelier MA, Bron EE, Mutsaerts HJ, Zwinderman AH, Groote IR, Rombouts SA, Lindauer RJ, Klein S, Niessen WJ, Opmeer BC, Boer F, Lucassen PJ, Andersen SL, Geurts HM, Reneman L (2016) Age-dependent effects of methylphenidate on the human dopaminergic system in young vs adult patients with attention-deficit/hyperactivity disorder: a randomized clinical trial. JAMA Psychiatry 73(9):955–962CrossRefGoogle Scholar
- Schultz W (2016) Dopamine reward prediction error coding. Dialogues Clin Neurosci 18(1):23–32Google Scholar
- Witten IB, Steinberg EE, Lee SY, Davidson TJ, Zalocusky KA, Brodsky M, Yizhar O, Cho SL, Gong S, Ramakrishnan C, Stuber GD, Tye KM, Janak PH, Deisseroth K (2011) Recombinase-driver rat lines: tools, techniques, and optogenetic application to dopamine-mediated reinforcement. Neuron 72(5):721–733CrossRefGoogle Scholar